About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Boston | 392 Studies

Clinical Trials Ovarian CancerBoston

Ovarian Cancer Clinical Trials in Boston

Find 392 clinical trials for ovarian cancer near Boston, Massachusetts. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 241-260 of 392 trials

Active not recruitingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor an NTRK1/2/3, ROS1, or ALK…NCT02568267·Phoenix, Arizona and 119 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingIntraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian CancerThe goal of this research study is to evaluate the safety and effectiveness of the use of cytokine-induced memory-like (CIML) natural killer (NK) cell therapy in recurrent, high…NCT06321484·Boston, Massachusetts and 1 other

Active not recruitingPembrolizumab and Lenvatinib in Clear Cell Ovarian CancerThis research study is being done to test the efficacy and safety of combining the study drugs pembrolizumab and lenvatinib in patients with clear cell ovarian cancer.NCT05296512·Chicago, Illinois and 2 others

Active not recruitingPaclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerThis phase III clinical trial studies two different dose schedules of paclitaxel to see how well they work in combination with carboplatin with or without bevacizumab in treating…NCT01167712·Birmingham, Alabama and 563 others

CompletedBevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the OvaryThis phase II trial studies how well bevacizumab works in treating patients with sex cord-stromal tumors of the ovary that have come back.NCT00748657·Los Angeles, California and 35 others

CompletedEribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerThis phase II trial is studying how well eribulin mesylate works in treating patients with recurrent ovarian epithelial, primary peritoneal cavity, or fallopian tube cancer.NCT00334893·Boston, Massachusetts and 1 other

CompletedStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerThe primary objective in Phase I is to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent administered in 21-day treatment cycles in…NCT01631552·Aurora, Colorado and 11 others

CompletedStudy of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerThe purpose of this study is to determine the biologically active dose of entinostat, when given in combination with avelumab, that is safe and warrants further investigation.NCT02915523·Tampa, Florida and 11 others

CompletedTemsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian CancerThis phase II trial studies how well temsirolimus, carboplatin, and paclitaxel as first-line therapy works in treating patients with newly diagnosed stage III-IV clear cell…NCT01196429·Phoenix, Arizona and 144 others

CompletedSunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasRATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00474994·Boston, Massachusetts and 1 other

CompletedYoung Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual FunctionThe purpose of this study is to ask youn women diagnosed with ovarian cancer who have undergone surgery that will allow them to have children in the future, on issues such as…NCT00525460·Boston, Massachusetts and 2 others

CompletedAcupuncture for Women's Health ConditionsThe purpose of this study is to evaluate the safety and effectiveness of acupuncture in treating women's health conditions.NCT00090389·Boston, Massachusetts

TerminatedA Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell CarcinomaThis is a study to determine the safety of CDX-014 and effectiveness (how well the drug works).NCT02837991·Scottsdale, Arizona and 4 others

RecruitingEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsThe objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and…NCT05983432·Beverly Hills, California and 36 others

CompletedA Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis is a Phase II, randomized, placebo-controlled, double-blind, multicenter clinical trial of pertuzumab in combination with gemcitabine relative to placebo in combination with…NCT00096993·Birmingham, Alabama and 40 others

CompletedTrial of Pimasertib With SAR245409 or Placebo in Ovarian CancerThis is a double blind, randomized, placebo-controlled, 2-arm, Phase 2 trial investigating the efficacy and safety of combination therapy of pimasertib plus SAR245409 and…NCT01936363·Augusta, Georgia and 33 others

Active not recruitingTesting the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal)…NCT05554328·Birmingham, Alabama and 294 others

CompletedAcupuncture to Improve Quality of Life in Patients With Advanced CancerThis study will test the feasibility of acupuncture as a complementary therapy for advanced cancer by comparing symptoms and quality of life before and after 8 weeks of…NCT00070967·Boston, Massachusetts

TerminatedA Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the OvaryThis is an open-label, First-in-Human, Phase 1/2, multicenter study to evaluate the safety and efficacy of a single dose of AVB-001.NCT05538624·Bethesda, Maryland and 4 others

CompletedA Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid TumorsThis is a study to determine the clinical benefit (how well the drug works), safety, and tolerability of combining varlilumab and nivolumab (also known as Opdivo® , BMS-936558).NCT02335918·Tucson, Arizona and 18 others

PreviousPage 13 of 20Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia